COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Insilico Medicine operates AI-driven platforms (PandaOmics, Chemistry42) for target discovery and generative chemistry, runs automated robotic laboratories, and advances in-house therapeutics across oncology, fibrosis, immunology, and CNS.
